Send Orders of Reprints at reprints@benthamscience.org
Current Medicinal Chemistry, 2012, 19, 5205-5213 5205
Non-Ribosomal Halogenated Protease Inhibitors from Cyanobacterial Isolates as
Attractive Drug Targets
M.E. Silva-Stenico, J. Rigonato, M.G. Leal, M.G.M.V. Vaz, A.P.D. Andreote and M.F. Fiore*
University of São Paulo, Center for Nuclear Energy in Agriculture, Laboratory of Molecular Ecology of Cyanobacteria, 13400-970
Piracicaba, SP, Brazil
Abstract: Cyanobacteria possess the ability to produce compounds with remarkable biological activity, and have thus attracted the
attention of the pharmaceutical industry. Cyanopeptides acting as protease inhibitors have shown potential in the field of pharmacother-
apy through regulation of abnormal physiological processes in the human body. Despite the already described cyanopeptide protease
inhibitors, the search for new congeners is of considerable interest which may pave the way for more efficient molecules. In this study,
the presence of the protease inhibitors aeruginosin and cyanopeptolin with non-, mono- and dichlorination and also genes coding for their
synthetases was investigated in 90 cyanobacterial strains. Mass spectrometry analyses highlighted production of 91, 19 and 3 non-,
mono- and dichlorinated congeners, respectively. The purified extract of Microcystis botrys SPC759 inhibited 61% of pepsin protease.
PCR amplifications of aeruginosin and cyanopeptolin synthetase gene regions were observed in 41 and 28% of evaluated strains,
respectively. The sequences obtained for the aerA-aerB (aeruginosin) and mcnC-mcnE (cyanopeptolin) gene regions grouped together
with their homologues found in other cyanobacterial strains in the phylogenetic analyses with high bootstrap support. Antimicrobial
activity assays performed using all intracellular extracts inhibited 31 and 26% of Gram-negative and Gram-positive pathogenic bacterial
growth, respectively. The results of this study showed the production of aeruginosin and cyanopeptolin and the presence of their genes in
several cyanobacterial genera for the first time besides the discovery of novel congeners.
Keywords: Antimicrobial, aeruginosin, bioactive peptides, chlorination, cyanobacteria, cyanopeptolin, mass spectrometry, natural products,
pepsin, protease inhibitors.
INTRODUCTION
Cyanobacteria are interesting microorganisms which can pro-
duce a significant variety of valuable molecules with potential for
pharmaceutical application. These natural products belong to sev-
eral classes of substances, including enzyme, photosynthesis and
Ca
2+
channel inhibitors, antibacterial, antimalarial, imunossuppres-
sor, antitumoral, antiprotozoal, antiviral and cytotoxic [1-3]. Most
of the cyanopeptides is synthesized by non-ribosomal pathway [4,
5] including the halogenated aeruginosins and cyanopeptolins [6].
Aeruginosins are natural linear peptides with protease inhibition
activity, characterized by the presence of four subunits: N-terminal
amino acid group (3-4 hydroxyphenyl lactic acid - Hpla), a
hydrophobic amino acid, a central residue 2-carboxy-6-hydroxy
octahydroindol (Choi) and a group with a guanidine-C terminal [7-
10]. Structural changes may occur in Hpla subunits (mono-, di-
chlorination and sulphation) and Choi (sulphation, glycosylation
and chlorination) Fig. (1A).
Cyanopeptolins belong to a class of cyclic peptides besides
being protease inhibitors. The general structure of this peptide class
is characterized by a branched peptidolactone, containing seven
amino acids, of which six form a ring [11]. All cyanopeptolins con-
tain the residue 3-amino-6-hydroxy-2-piperidone (Ahp) and the
peptide cyclization occurs by an ester bond of the -hydroxy group
of threonine with the carboxy group of the terminal amino acid [12]
Fig. (1B).
Both aeruginosins and cyanopeptolins can be synthesized as
non- mono- or di-chlorinated molecules. The genes aerJ and mcnD
have been suggested to be involved in the production of chlorinated
aeruginosin and cyanopeptolin, respectively [6]. The presence or
absence of a chlorine atom in these peptides may modulate their
inhibition activity [13]. For example, the chlorinated
chlorodysinosin A has a potent effect against thrombin, while
dysinosin A containing hydrogen instead of chlorine is less
effective [8]. Here we present data showing the natural diversity of
*Address correspondence to this author at the University of São Paulo, Center for
Nuclear Energy in Agriculture, Molecular Ecology of Cyanobacteria Laboratory,
13400-970, Piracicaba-SP, Brazil; Tel: +55 19 3429 4657; Fax: +55 19 3429 4610;
E-mail: fiore@cena.usp.br
Fig. (1). Chemical structure of cyanopeptides protease inhibitors: A) Aeru-
ginosin 98-A; B) Cyanopeptolin A. Structures adapted from Welker & von
Döhren [22].
1875-533X/12 $58.00+.00 © 2012 Bentham Science Publishers